2005
Top
Vol. 31
December December 2005 No. 8, p591
November November 2005 No. 7, p507
October October 2005 No. 6, p423
August August 2005 No. 5, p339
June June 2005 No. 4, p247
May May 2005 No. 3, p159
April April 2005 No. 2, p69
February February 2005 No. 1, p1
Supplement 4 2005,
Improving Outcomes for Patients in Breast Cancer
Supplement 3 2005, p1
Evidence and Experience: Zoledronic Acid in Cancer Induced Bone Disease Proceedings of a Satellite symposium held during the 5th International Conference on Cancer-induced Bone Disease, Davos, Switzerland, 20–24 March 2005
Supplement 2 2005,
Fulvestrant (‘Faslodex’) in Clinical Practice: International Experience from the Compassionate Use Programme
Supplement 1 2005, p1
Vth International Conference on Cancer-Induced Bone Disease
2004
Top
Vol. 30
December December 2004 No. 8, p671
November November 2004 No. 7, p599
October October 2004 No. 6, p495
August August 2004 No. 5, p405
June June 2004 No. 4, p325
May May 2004 No. 3, p237
April April 2004 No. 2, p153
February February 2004 No. 1, p1
2003
Top
Vol. 29
December December 2003 No. 6, p461
October October 2003 No. 5, p355
August August 2003 No. 4, p241
June, Supplement 2 June 2003, p1
June June 2003 No. 3, p149
Prostate Cancer
May, Supplement 1 May 2003, p1
April April 2003 No. 2, p79
February February 2003 No. 1, p1
